Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
17 hedge funds and large institutions have $4.76M invested in Chembio diagnostics, Inc. in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
6% less funds holding
Funds holding: 18 → 17 (-1)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
46% less capital invested
Capital invested by funds: $8.82M → $4.76M (-$4.06M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$482K |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$72.1K |
| 3 |
Citigroup
New York
|
+$15.1K |
| 4 |
RNS
Robert N. Shapiro
|
+$3.71K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$2.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$1.62M |
| 2 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$903K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$270K |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$105K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$26.3K |
CEMI Hedge Fund Activity: Q3 2013 in Review
17 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q3 2013, worth a combined $4.76M — down 46% from $8.82M a quarter earlier.
Fund positioning in CEMI was balanced in Q3 2013: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $482K. The largest seller was Northpointe Capital, exiting entirely with an estimated $1.62M sold.
- 17 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q3 2013, down from 18 in Q2 2013.
- Funds reported $4.76M of Chembio diagnostics, Inc. stock for Q3 2013, down 46% quarter-over-quarter.
- 4 funds opened new Chembio diagnostics, Inc. positions in Q3 2013 and 4 closed out, a net change of 0 holders.
- The largest Chembio diagnostics, Inc. buyer in Q3 2013 was Vanguard Group, an estimated $482K added.
- The largest Chembio diagnostics, Inc. seller in Q3 2013 was Northpointe Capital, an estimated $1.62M sold.
Based on aggregated 13F filings for Q3 2013.